Preclinical News and Research

RSS
Researchers develop chemically modified phage capsid that “stifles” influenza viruses

Researchers develop chemically modified phage capsid that “stifles” influenza viruses

31 Mar 2020
Moffitt scientists identify potential therapeutic targets for cutaneous squamous cell carcinoma

Moffitt scientists identify potential therapeutic targets for cutaneous squamous cell carcinoma

30 Mar 2020
UAB will collaborate with Altimmune to test a COVID-19 vaccine candidate

UAB will collaborate with Altimmune to test a COVID-19 vaccine candidate

30 Mar 2020
How long to a coronavirus vaccine?

How long to a coronavirus vaccine?

29 Mar 2020
Fast-acting anti-malarial compound shows promise in first clinical trial

Fast-acting anti-malarial compound shows promise in first clinical trial

27 Mar 2020
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19

Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19

From GRIFOLS U.K. Ltd. 27 Mar 2020
Targeting specific histone deacetylase may be novel therapeutic strategy for NSCLC

Targeting specific histone deacetylase may be novel therapeutic strategy for NSCLC

26 Mar 2020
Why Primary Cells Are Important for In Vitro ADME-Tox Studies

Why Primary Cells Are Important for In Vitro ADME-Tox Studies

From Lonza 26 Mar 2020
Preclinical study characterizes the binding affinity and selectivity of a selective FLT3 inhibitor

Preclinical study characterizes the binding affinity and selectivity of a selective FLT3 inhibitor

21 Mar 2020
MILabs enhances preclinical diagnostic U-CT system for COVID-19 research

MILabs enhances preclinical diagnostic U-CT system for COVID-19 research

20 Mar 2020
CARB-X awards $2.86M to develop novel oral antibiotic to treat drug-resistant gonorrhea

CARB-X awards $2.86M to develop novel oral antibiotic to treat drug-resistant gonorrhea

20 Mar 2020
Targeting PI3Kβ alone and with combination therapy in PTEN-deficient tumors

Targeting PI3Kβ alone and with combination therapy in PTEN-deficient tumors

18 Mar 2020
Gyrolab technology to be incorporated into Jefferson Institute for Bioprocessing specialized teaching curriculum and training programs

Gyrolab technology to be incorporated into Jefferson Institute for Bioprocessing specialized teaching curriculum and training programs

From Gyros Protein Technologies AB 17 Mar 2020
Trial of cancer drug OxaliTex promises lower toxicity and more robust action

Trial of cancer drug OxaliTex promises lower toxicity and more robust action

16 Mar 2020
Administering specialized lipids prevents memory loss, inflammation in Down syndrome mouse model

Administering specialized lipids prevents memory loss, inflammation in Down syndrome mouse model

13 Mar 2020
UC Riverside biochemist and Atomwise form new joint venture

UC Riverside biochemist and Atomwise form new joint venture

13 Mar 2020
New recommendations for evaluation of bladder and bowel dysfunction after spinal cord injury

New recommendations for evaluation of bladder and bowel dysfunction after spinal cord injury

12 Mar 2020
BIN1 deficit leads to impaired spatial learning and memory

BIN1 deficit leads to impaired spatial learning and memory

11 Mar 2020
Researchers find way to inactivate cancer protein with the help of another protein

Researchers find way to inactivate cancer protein with the help of another protein

10 Mar 2020
Marinomed extends the range of Marinosolv applications

Marinomed extends the range of Marinosolv applications

From Marinomed Biotech AG 10 Mar 2020

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback